Dr. Anand Somkuwar, Dr. Archit Gupta


We report a genetically confirmed case of Huntington’s disease and its evaluation of MRI brain parameters. Huntington’s disease (HD) is an autosomal dominant disorder characterised by involuntary movements, dementia, and behavioural disturbances. MRI Brain parameters (FH/CC AND CC/IT RATIOS) are very specific for evaluation of HD and adds to the diagnosis OF HD. Diagnosis can be confirmed by genetic testing of CAG nucleotide repeats


Huntington disease, Autosomal dominant, CAG nucleotide repeats, MRI Brain parameters.

Full Text:



Ahmad R, Bourgeois S, Postnov A, Schmidt ME, Bormans G, Van Laere K, Vandenberghe W. PET imaging shows loss of striatal PDE10A in patients with Huntington disease. Neurology.2014;82(3):279-81.

Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology. 2003;60:1615-20.

Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology. 2004;63:989-95.

Kassubek J, Juengling FD, Kioschies T, Henkel K, Karitzky J, Kramer B, Ecker D, Andrich J, Saft C, Kraus P, Aschoff AJ, Ludolph AC, Landwehrmeyer GB. Topography of cerebral atrophy in early Huntingdon’s disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry. 2004;75:213-20.

Goldberg YP, Andrew SE, Clarke LA, Hayden MR. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum Mol Genet. 1993;2:635-6.

McInnis MG. Anticipation: an old idea in new genes. Am J Hum Genet. 1996;59:973-9.


  • There are currently no refbacks.